Article Details
Retrieved on: 2021-07-14 08:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ikena Oncology Inc (NASDAQ:IKNA) fell 16.5% to close at $12.72. ... (pembrolizumab) in patients with metastatic melanoma and head & neck cancer.
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here